Home
Mail
News
Sport
Finance
Celebrity
Style
Weather
Mobile
Messenger
Movies
More
Yahoo
Mail
News
Market Data
Crypto
Bank of England
Money Matters
Property
Top Stocks
Work & Management
Industry News
Brexit
My Portfolio
My Screeners
Watchlists
Videos
UK markets closed
FTSE 100
8,420.26
-18.39
(-0.22%)
FTSE 250
20,749.90
-72.94
(-0.35%)
AIM
794.02
+1.52
(+0.19%)
GBP/EUR
1.1678
+0.0023
(+0.20%)
GBP/USD
1.2706
+0.0035
(+0.28%)
Bitcoin GBP
52,907.23
+689.31
(+1.32%)
Ocuphire Pharma, Inc. (R3X1.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
1.5300
-0.0360
(-2.30%)
At close: 09:55PM CEST
Summary
Chart
Conversations
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
Currency in USD.
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
19,011
19,049
39,850
589
0
Operating expenses
Research development
16,807
17,653
14,355
15,173
6,648
Selling general and administrative
14,344
11,959
7,269
8,121
2,818
Total operating expenses
31,151
29,612
21,624
23,294
9,466
Operating income or loss
-12,140
-10,563
18,226
-22,705
-9,466
Interest expense
-
0
9
2
6,847
Total other income/expenses net
1,946
1,917
-14
-33,986
-8,307
Income before tax
-11,289
-9,974
18,203
-56,693
-24,620
Income tax expense
12
12
315
0
0
Income from continuing operations
-11,301
-9,986
17,888
-56,693
-24,620
Net income
-11,301
-9,986
17,888
-56,693
-24,620
Net income available to common shareholders
-11,301
-9,986
17,888
-56,693
-24,620
Basic EPS
1.47
-0.46
0.90
-3.82
-5.28
Diluted EPS
1.44
-0.46
0.87
-3.82
-5.28
Basic average shares
21,042
21,590
19,931
14,853
4,661
Diluted average shares
21,708
21,590
20,597
14,853
4,661
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.